Cidara Therapeutics Inc
NASDAQ:CDTX
| Market Cap (Intraday) | 92.06M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.03 |
| 50-Day MA | $0.96 |
| 200-Day MA | $1.14 |
Cidara Therapeutics Inc Stock, NASDAQ:CDTX
6310 Nancy Ridge Drive, Suite 101, San Diego, California 92121
United States of America
Phone: +1.858.752.6170
Number of Employees: 73
Description
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of therapeutics for patients facing serious diseases, specifically oncology and infectious diseases. Its product pipeline includes Rezafungin Acetate and Cloudbreak. The company was founded by Kevin M. Forrest, Kevin J. Judice, and H. Shaw Warren in December 2012 and is headquartered in San Diego, CA.